# Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of Friday, December 7, 2012 (77 FR 73034). The product name in the document was incorrect. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Natasha Facey, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-5290, *[email protected].*
**SUPPLEMENTARY INFORMATION:**
In FR doc. 2012-29538, appearing on page 73034 in the *Federal Register* of Friday, December 7, 2012, the following correction is made:
1. On page 73034, in the second column under the section entitled “Agenda”, the product name “NeuroPace Responsive Neurostimulation (RNS) System” is corrected to read “NeuroPace RNS System”.
Dated: December 7, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.